HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Miconazole

HCID 4189
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
22916-47-8
Standard SMILES
Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
Molecular formula
C18H14Cl4N2O
Average molar mass
416.1 g/mol
Monoisotopic mass
413.986024

Overview

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole is a member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group. It is a dichlorobenzene, a member of imidazoles and an ether.

Names & identifiers

Preferred name
Miconazole
IUPAC
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
English name
Miconazole
Molecular formula
C18H14Cl4N2O
Molecular weight
416.13

Names & synonyms

miconazole22916-47-8Daktarin IVMiconazolMiconazoloMiconazolum1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazoleDaktarinOravig1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-DTXSID6023319
Show more names
MICONAZOLE BASE1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (9CI)r18134mjr1762R 18134MinostateNSC 170986Miconozole
7NNO0D7S5M1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-DTXCID803319Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-NSC170986DermazoleDumicoat

Database identifiers

CAS

Properties

Computed structural propertiesFilling in

XLogP
5.3
Topological polar surface area
27.1 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
6
Heavy atoms
25
Formal charge
0
Complexity
417

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals

PesticidesBiocide
LogP · 2 items

6.1

5.81

Solubility7.63e-04 g/L
Human Drugs · 4 items

Breast Feeding; Lactation; Milk, Human; Antifungal Agents; Dermatologic Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Dermatological medicines > Antifungal medicines

Endocrine DisruptorsPotential endocrine disrupting compound
Melting Point159 - 163 °C
Physical DescriptionSolid
Collision Cross Section187.51 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 1% (1 of 104) of reports.

Warning

H302 (98.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P273, P301+P317, P330, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 104 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory InformationMiconazole: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Other Safety InformationIMAP assessments - 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (98.1%)

Toxicology

Exposure RoutesTopical
Toxicity Summary · 1 item

Miconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Miconazole may also inhibit endogenous respiration, interact with membrane phospholipids, inhibit the transformation of yeasts to mycelial forms, inhibit purine uptake, and impair triglyceride and/or phospholipid biosynthesis.

Chemistry & industry

Pharmacology

ATC Code · 6 items

D01AC02

D - Dermatologicals

S - Sensory organs

G - Genito urinary system and sex hormones

J - Antiinfectives for systemic use

A - Alimentary tract and metabolism

Protein Binding_In vitro_ data suggests that miconazole binds human serum albumin, however, the clinical significance of this observation is unclear.
Pharmacodynamics · 1 item

Miconazole is an azole antifungal that functions primarily through inhibition of a specific demethylase within the CYP450 complex. As miconazole is typically applied topically and is minimally absorbed into the systemic circulation following application, the majority of patient reactions are limited to hypersensitivity and cases of anaphylaxis. Patients using intravaginal miconazole products are advised not to rely on contraceptives to prevent pregnancy and sexually transmitted infections, as well as not to use tampons concurrently.

Mechanism of Action · 1 item

Miconazole is an azole antifungal used to treat a variety of conditions, including those caused by _Candida_ overgrowth. Unique among the azoles, miconazole is thought to act through three main mechanisms. The primary mechanism of action is through inhibition of the CYP450 14α-lanosterol demethylase enzyme, which results in altered ergosterol production and impaired cell membrane composition and permeability, which in turn leads to cation, phosphate, and low molecular weight protein leakage. In addition, miconazole inhibits fungal peroxidase and catalase while not affecting NADH oxidase activity, leading to increased production of reactive oxygen species (ROS). Increased intracellular ROS leads to downstream pleiotropic effects and eventual apoptosis. Lastly, likely as a result of lanosterol demethylation inhibition, miconazole causes a rise in intracellular levels of farnesol. This molecule participates in quorum sensing in _Candida_, preventing the transition from yeast to mycelial forms and thereby the formation of biofilms, which are more resistant to antibiotics. In addition, farnesol is an inhibitor of drug efflux ABC transporters, namely _Candida_ CaCdr1p and CaCdr2p, which may additionally contribute to increased effectiveness of azole drugs.

Related reactions

33 records
New reaction record
HRID 200761 reaction equation
HRID 200761As reactant
HRID 328633 reaction equation
HRID 328633As reactant
HRID 328634 reaction equation
HRID 328634As reactant
HRID 328635 reaction equation
HRID 328635As reactant
HRID 328636 reaction equation
HRID 328636As reactant
HRID 328637 reaction equation
HRID 328637As reactant
HRID 328638 reaction equation
HRID 328638As reactant
HRID 328639 reaction equation
HRID 328639As reactant
PreviousPage 1 of 5

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
22916-47-8
PubChem CID
4189
DTXSID
DTXSID6023319
ChEMBL
CHEMBL91
ChEBI
CHEBI:82892
UNII
7NNO0D7S5M
EC Number
245-324-5
Nikkaji
J11.471E

Physicochemical properties

Melting point
159 · 159-163C
Boiling point
555.1 · 555.1±50.0 °C(Predicted)
Density
1.5326 · 1.5326 (rough estimate)
refractive index
1.62 · 1.6200 (estimate)
RTECS
4770000 · NI4770000
Flash point
87 ° · 87°(189°F)
storage temp.
Sealed in dry,Room Temperature
solubility
Very slightly soluble in water, freely soluble in methanol, soluble in ethanol (96 per cent).
form
Solid
pka
6.91 · pKa 6.91(H2O,t =25) (Uncertain)
color
White to Off-White
Water Solubility
Freely soluble in alcohols or acetone. Also soluble in DMF or chloroform. Insoluble in water
Sensitive
Light Sensitive
Major Application
pharmaceutical (small molecule)
InChI
1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2
InChIKey
BYBLEWFAAKGYCD-UHFFFAOYSA-N
SMILES
Clc1c(ccc(c1)Cl)C(OCc3c(cc(cc3)Cl)Cl)C[n]2cncc2
CAS DataBase Reference
22916 · 22916-47-8(CAS DataBase Reference)
EWG's Food Scores
1 · 1
FDA UNII
7 NNO0D7S5M · 7NNO0D7S5M
ATC code
1 AB09,A07AC01,D01AC02,D01AC52,G01AF04,J02AB01,S02AA13 · A01AB09,A07AC01,D01AC02,D01AC52,G01AF04,J02AB01,S02AA13
NIST Chemistry Reference
Miconazole(22916-47-8)
EPA Substance Registry System
1 H-Imidazole, · 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]- (22916-47-8)
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Protein binding
90 % · 90%
Excreted unchanged in urine
1 % · 1%
Volume of distribution
20 · 20(L/kg)
Biological half-life
24 · 24 / Unchanged
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H413
Precautionary statements
264 · P264-P270-P273-P301+P312-P501
Hazard Codes
Xn
Risk Statements
22 · 22
Safety Statements
22 · 22-36
RIDADR
3249 · 3249
WGK Germany
3 · 3
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
2933290000 · 2933290000
Storage Class
11 · 11 - Combustible Solids
Hazard Classifications
4 OralAquatic · Acute Tox. 4 OralAquatic Chronic 4
Signs and SymptomsIngestion of the amounts of the components contained in a tube of cream are unlikely to produce overdosage and toxic effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 5 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

miconazole

DILI Negative

Topical

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation · 2 items

◉ Summary of Use during Lactation

◈ What is miconazole?

Toxicity DataLD50: 3800 mg/kg (Oral, Mouse) (A308) LD50: 3 gm/kg (Oral, Rat) (A308)
EPA Human Health Benchmarks for Pharmaceuticals · 6 items

Miconazole

1.2

4.9

The recommended dosing schedule for miconazole is the application of one 50 mg buccal tablet to the upper gum region (canine fossa) once daily for 14 consecutive days.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 50 mg/day, Lowest Therapeutic Dose (LTD): 0.6 mg/kg-day, and Screening Dose: 0.0002 mg/kg-day.

1-Jan-22

Safety data

wgk
3
ridadr
3249
hs_code
2933290000
risk_code
22
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xn
safety_code
22-36
hazard_class
6.1(b)
Storage Class
11 - Combustible Solids
packing_group
III
Hazard statements
H302-H413
Hazard Classifications
Acute Tox. 4 OralAquatic Chronic 4
Precautionary statements
P264-P270-P273-P301+P312-P501
Biological Half-LifeMiconazole has a terminal half-life of 24 hours.
Metabolism/MetabolitesMiconazole is metabolized in the liver and does not give rise to any active metabolites.
FDA Pharmacological Classification · 6 items

7NNO0D7S5M

MICONAZOLE

Established Pharmacologic Class [EPC] - Azole Antifungal

Chemical Structure [CS] - Azoles

Miconazole is an Azole Antifungal.

MICONAZOLE

MeSH Pharmacological Classification · 4 items

Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.

Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2C9.

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP3A.

Absorption, Distribution and Excretion · 3 items

Miconazole given to healthy volunteers as a single 50 mg oral tablet produced a mean Cmax of 15.1 ± 16.2 mcg/mL, a mean AUC0-24 of 55.2 ± 35.1 mcg\*h/mL, and a median Tmax of 7 hours (range 2.0-24.1). In these patients measurable plasma concentrations ranged from 0.5 to 0.83 mcg/mL. Topical miconazole is absorbed poorly into the systemic circulation. In pediatric patients aged 1-21 months given multiple topical applications of miconazole ointment for seven days, the plasma miconazole concentration was less than 0.5 ng/mL in 88% of the patients, with the remaining patients having a concentration of 0.57 and 0.58 ng/mL, respectively. Similarly, patients. administered with a vaginal 1200 mg ovule had a mean Cmax of 10.71 ng/mL, mean Tmax of 18.4 hours, and mean AUC0-96 of 477.3 ng\*h/mL.

Miconazole is excreted through both urine and feces; less than 1% of unchanged miconazole is recovered in urine.

A 1200 mg miconazole vaginal suppository resulted in a calculated apparent volume of distribution of 95 546 L while a 100 mg vaginal cream yielded an apparent volume of distribution of 10 911L.

Cellular LocationsCytoplasm

Uses & manufacturing

Uses · 2 items

Use (kg; approx.) in Germany (2009): >1000

For topical application in the treatment of tinea pedis (athlete&rsquo;s foot), tinea cruris, and tinea corporis caused by <i>Trichophyton rubrum</i>, <i>Trichophyton mentagrophytes</i>, and <i>Epidermophyton floccosum</i>, in the treatment of cutaneous candidiasis (moniliasis), and in the treatment of tinea versicolor.

Applications · 3 items

UsesMiconazole, is used as an antifungal inhibitor of aromatase. Miconazole has been shown to promote remyelination of neurons in chronic progressive multiple sclerosis mouse models. Miconazole is mainly used externally for the treatment of athlete's foot, ringworm, and jock itch. Internal application is used for oral or vaginal thrush (yeast infection). The oral gel may also be used for the lip disorder angular cheilitis. It is also used in photography.

UsesMiconazole is an antifungal agent of the imidazole type. It is used in topical and vaginal preparations to prevent growth of dermatophytes, yeast, and molds.

UsesAntifungal;Sterol 14-demethylase inhibitor. Miconazole (Monistat-Derm, Micatin, etc.) is a synthetic imidazole antifungal compound that acts by altering cell membrane permeability. It is effective against most dermatophyte species, P. orbiculare, and C. albicans.

Upstream & downstream products

Upstream raw materials

2,4'-Dichloroacetophenone2,4-Dichlorobenzyl chloride1-(2,4-Dichlorophenyl)-2-(1H-imidazole-1-yl) ethanone(2,4-dichlorophenyl)oxiranealpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol2,2',4'-Trichloroacetophenone

Downstream products

SULCONAZOLE
Additional notes · 1 item

DefinitionChEBI: 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole is a member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group. It is an ether, a member of imidazoles and a dichlorobenzene.